Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/06/29/2697420/32478/en/Calithera-Biosciences-Announces-Update-on-Complete-Liquidation-and-Dissolution.html
https://www.globenewswire.com/news-release/2023/05/19/2672782/32478/en/Calithera-Biosciences-Announces-Update-on-Complete-Liquidation-and-Dissolution.html
https://www.globenewswire.com/news-release/2023/01/09/2585158/32478/en/Calithera-Biosciences-Announces-Board-Approval-of-Complete-Liquidation-and-Dissolution.html
https://endpts.com/calithera-to-shut-down-after-failing-to-revive-takeda-assets/
https://www.globenewswire.com/news-release/2022/11/14/2555452/32478/en/Calithera-Biosciences-Reports-Third-Quarter-2022-Financial-Results-and-Business-Update.html
https://www.globenewswire.com/news-release/2022/11/08/2551507/32478/en/Calithera-Biosciences-to-Report-Third-Quarter-2022-Financial-Results-on-Monday-November-14-2022.html
https://www.globenewswire.com/news-release/2022/10/03/2526655/0/en/Calithera-Receives-FDA-Fast-Track-Designation-for-Sapanisertib-for-the-Treatment-of-NRF2-mutated-Squamous-Lung-Cancer.html
https://www.globenewswire.com/news-release/2022/09/06/2510909/32478/en/Calithera-to-Present-at-the-H-C-Wainwright-24th-Annual-Global-Investment-Conference.html
https://www.globenewswire.com/news-release/2022/08/15/2498526/32478/en/Calithera-Biosciences-Reports-Second-Quarter-2022-Financial-Results-and-Recent-Highlights.html
https://www.globenewswire.com/news-release/2022/08/08/2494273/32478/en/Calithera-Biosciences-to-Report-Second-Quarter-2022-Financial-Results-on-Monday-August-15-2022.html